Physician profile
Joseph L Smith
NPI 1043251051
$7,559.03
in general payments reported to CMS, 2019-2025
40 companies · $2,066 in 2025
The $2,066 reported for 2025 was more than what 91% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $604 · 2021: $826 · 2022: $1,258 · 2023: $635 · 2024: $1,610 · 2025: $2,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,778 · Education: $384 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,777.91 |
| Education | $383.62 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,700.21 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $832.68 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $501.26 | 2019-2025 | Dupixent, Libtayo |
| Glaxosmithkline, LLC. | $455.58 | 2019-2025 | Nucala |
| Avadel Cns Pharmaceuticals, LLC | $338.86 | 2024-2025 | Lumryz |
| Axsome Therapeutics, INC. | $296.12 | 2024-2025 | Sunosi |
| Stryker Corporation | $283.19 | 2019-2025 | Xpress Loprofile |
| Genzyme Corporation | $282.93 | 2019-2025 | |
| Optinose US, INC. | $282.65 | 2019-2025 | |
| Genentech USA, INC. | $274.17 | 2019-2025 | Xolair |
| Lilly USA, LLC | $265.37 | 2024-2025 | Zepbound |
| Intersect Ent, INC. | $252.06 | 2020-2022 | |
| Aimmune Therapeutics, INC. | $237.70 | 2021-2022 | |
| Alk-Abello, INC | $135.87 | 2019-2025 | Alternaria Tenuis, Pre-Pen, Standardized Mite D. Farinae |
| Astrazeneca Pharmaceuticals Lp | $123.33 | 2019-2024 | Fasenra |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $108.63 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $102.88 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $94.99 | 2023 | |
| Aerin Medical INC. | $94.95 | 2019-2025 | |
| Phathom Pharmaceuticals, INC. | $92.98 | 2024-2025 | Voquezna |
| Acclarent, INC | $91.23 | 2019-2023 | Trudi Nav Cable |
| Kaleo, INC. | $77.49 | 2019-2024 | Auvi-Q |
| Neurent Medical Limited | $65.98 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $63.47 | 2025 | Neffy |
| Resmed Corp | $56.84 | 2019-2024 | |
| Vertex Pharmaceuticals Incorporated | $47.19 | 2025 | |
| Integra Lifesciences Corporation | $46.30 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Eisai INC. | $44.73 | 2021 | |
| Amgen INC. | $43.74 | 2020-2022 | |
| Azurity Pharmaceuticals, INC. | $39.86 | 2024 | Horizant |
| Medtronic, INC. | $35.66 | 2022-2025 | Propel |
| Fiagon Na LLC | $27.58 | 2020 | |
| 3b Medical, INC. | $27.02 | 2025 | Luna |
| Takeda Pharmaceuticals U.S.A., INC. | $22.32 | 2020 | |
| Pfizer INC. | $20.82 | 2023 | |
| Sanofi US Services INC. | $20.42 | 2024 | |
| Inspire Medical Systems, INC. | $19.80 | 2023 | Inspire |
| Tactile Systems Technology INC | $19.72 | 2024 | Entre Plus, Flexitouch Plus |
| Medtronic USA, INC. | $16.36 | 2020 | |
| Arbor Pharmaceuticals, INC. | $16.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.